1174 related articles for article (PubMed ID: 6976989)
41. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
42. Conjugate formation between effector and target as a function of cytotoxicity in antibody-dependent killing of AK-5 tumor.
Kausalya S; Pardhasaradhi BV; Manogaran PS; Khar A
Indian J Exp Biol; 1995 Mar; 33(3):161-4. PubMed ID: 7601484
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of proliferative and cytotoxic activities of human T lymphocytes with rabbit antibodies directed against leucoagglutinin-reactive T cell surface components.
Berzins T; Axelsson B; Hammarström ML; Hammarström S; Perlmann P
Eur J Immunol; 1984 Dec; 14(12):1145-52. PubMed ID: 6335097
[TBL] [Abstract][Full Text] [Related]
44. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
45. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
46. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
Waterfield JD; Nixon DF; Mair MG
Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
[TBL] [Abstract][Full Text] [Related]
47. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.
Fuson EW; Shaw MW; Hubbard RA; Lamon EW
Clin Exp Immunol; 1979 Oct; 38(1):158-65. PubMed ID: 316751
[TBL] [Abstract][Full Text] [Related]
48. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
49. Effect of Con A stimulation on antibody dependent cell-mediated cytotoxicity of human lymphocyte subpopulations.
Michałkiewicz J; Gajl-Peczalska K
Arch Immunol Ther Exp (Warsz); 1983; 31(2):161-9. PubMed ID: 6228202
[TBL] [Abstract][Full Text] [Related]
50. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
Nelson DL; Poplack DG; Holiman BJ; Henkart PA
Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
[TBL] [Abstract][Full Text] [Related]
51. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
52. Functional heterogeneity of helper T cells: two distinct helper T cells are required for the production of T cell growth factor.
Larsson EL
J Immunol; 1982 Feb; 128(2):742-5. PubMed ID: 6798123
[TBL] [Abstract][Full Text] [Related]
53. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness.
Kirk AD; Li RA; Kinch MS; Abernethy KA; Doyle C; Bollinger RR
Transplantation; 1993 Apr; 55(4):924-31. PubMed ID: 8475569
[TBL] [Abstract][Full Text] [Related]
54. Cyclosporin A renders target cells resistant to immune cytolysis.
Hudnall SD
Eur J Immunol; 1991 Jan; 21(1):221-6. PubMed ID: 1846819
[TBL] [Abstract][Full Text] [Related]
55. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
[TBL] [Abstract][Full Text] [Related]
56. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
Christiaansen JE; Burnside SS; Sears DW
J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
[TBL] [Abstract][Full Text] [Related]
57. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
58. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency.
Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T
J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277
[TBL] [Abstract][Full Text] [Related]
59. In vitro natural killer cell activity in the spontaneously diabetic BB/Wor rat: effects of serum on lysis of insulinoma cells.
Koevary SB
Diabetes Res; 1988 Jun; 8(2):77-84. PubMed ID: 2852569
[TBL] [Abstract][Full Text] [Related]
60. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
Fuson EW; Cole AJ; Hubbard RA
J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
